home / stock / tsvt / tsvt news

TSVT News and Press, 2seventy bio Inc. From 12/08/23

Stock Information
Company Name: 2seventy bio Inc.
Stock Symbol: TSVT
Market: NASDAQ
Website: 2seventybio.com
Menu
TSVT TSVT Quote TSVT Short TSVT News TSVT Articles TSVT Message Board
Get TSVT Alerts

News, Short Squeeze, Breakout and More Instantly...
TSVT - FSLR, MTTR and SBRA are among after hour movers

2023-12-08 16:43:19 ET Gainers: IGM Biosciences, Inc. ( IGMS ) +9% . EF Hutton Acquisition Corporation I ( EFHT ) +6% . Biomea Fusion ( BMEA ) +5% . Larimar Therapeutics ( LRMR ) +2% . First Solar ( FSLR ) +1% . Losers: L...
TSVT - ALT, CONN and VRNT are among after hour movers

2023-12-06 16:37:38 ET Verint Systems  ( VRNT ) +11% . ZyVersa Therapeutics ( ZVSA ) +6% . Couchbase ( BASE ) +4% . Grayscale Solana Trust  ( OTCQB:GSOL ) +4% . Cabaletta  ( CABA ) +3% . Vivid Seats ( SEAT ) ...

TSVT - Best Penny Stocks To Buy? 4 To Watch With Big News This Week

2023-12-06 14:48:10 ET Penny Stocks – How News Makes These Small Caps Soar or Plunge Penny stocks , securities with share prices under $5, offer investors a chance at exponential returns with little upfront investment. However, investing wisely in penny stocks require...

TSVT - Bristol Myers wins FDA label expansion for CAR T therapy Abecma

2023-12-06 14:45:26 ET More on Bristol-Myers Bristol-Myers Squibb Is A Great Buy, But These 5+% Yielding Bargains Are Better Bristol-Myers Squibb: The Patent Expiry Challenge Bristol Myers Squibb: A Bitter Pill But Still A Buy Bristol Myers gets priority revi...
TSVT - 2seventy bio Reiterates Commitment to Maximizing Shareholder Value

2seventy bio, Inc. (NASDAQ: TSVT), (“2seventy” or “the Company”), a leading immuno-oncology cell therapy company, today issued the following statement reiterating its commitment to maximizing shareholder value: As we indicated last month, the Board has commenced a ...

TSVT - 2seventy Bio gains amid push from activist investor Engine Capital

2023-12-06 12:32:02 ET More on 2seventy bio 2seventy bio, Inc. (TSVT) Q3 2023 Earnings Call Transcript bluebird bio And 2seventy bio - Spinner And Spun: The Better Bet In Cell Therapy FDA probing serious risk of T-cell malignancies in CAR-T cell therapy patients (upd...

TSVT - FDA investigating serious risk of T-cell malignancies in CAR-T cell therapy patients

2023-11-28 10:52:22 ET The U.S. Food and Drug Administration (FDA) on Tuesday said it was looking into reports of T-cell malignancies in patients who have been treated with CAR-T cell immunotherapies directed towards the proteins BCMA and CD19. The regulator said it had determined that ...
TSVT - MCRB, CYTO and TGS among mid-day movers

2023-11-20 12:59:05 ET Gainers: Mira Pharmaceuticals ( MIRA ) +58% . YPF ADR ( YPF ) +39% . Altamira Therapeutics Ltd ( CYTO ) +39% . ProKidney Corp ( PROK ) +35% . Soluna Holdings ( SLNH ) +32% . Safety Shot ( SHOT ) +...

TSVT - LRHC, SGD and NSTG among pre-market losers

2023-11-20 08:24:45 ET Losers: Syntec Optics Holdings ( OPTX ) -15% . Safe and Green Development Corp ( SGD ) -14% . Plus Therapeutics ( PSTV ) -14% reports new interim reSPECT-GBM phase 2 trial data at the society for NeuroOncology annual meeting. ...

TSVT - Bristol Myers, 2seventy bio to face FDA AdCom for Abecma label expansion

2023-11-20 07:34:54 ET More on Bristol-Myers Bristol Myers Squibb: Bright Future Ahead Bristol-Myers Squibb Company (BMY) Management Presents at Jefferies London Healthcare Conference (Transcript) Bristol-Myers Squibb Company (BMY) Management Presents at 2023 UBS Bio...
Previous 10 Next 10